ArticleJAMA oncology2026
Disparities in Cancer Incidence by Sex and Associated Lifestyle Factors and Health Conditions.
Article in JAMA oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Cancer risk is higher in males than females globally. Whether this sex disparity reflects a biological inevitability or is potentially modifiable by lifestyle behaviors and health conditions across diverse populations remains unclear. Objective: To determine the contribution of lifestyle factors and health conditions to sex disparities in cancer incidence across populations. Design, Setting, and Participants: This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank) of adults aged 40 to 74 years at baseline with no prior cancer. Baseline data were collected from 1997 to 2010, with follow-up through 2021. Data were analyzed from September 2025 to June 2026. Exposures: Eleven risk factors covering behaviors (smoking, heavy alcohol drinking, physical inactivity), diet (low intakes of vegetable and fruit, high intakes of red meat and processed meat), and health conditions (cholelithiasis, chronic liver diseases, diabetes, obesity). Main Outcomes and Measures: Incidence of 34 non-sex-specific cancer end points. Attributable rate differences (ARDs, cases per 100 000 person-years) and attributable proportion (AP, %) quantified the number and percentage of the male-female incidence rate gap attributable to the exposures. Results: Among a total of 589 766 participants (mean [SD] age, 56.1 [8.5] years; 315 813 [53.5%] females), 70 300 non-sex-specific cancer cases were documented. In the Chinese population (134 742 participants [54.4% female]), the joint ARD across the 11 risk factors was 182.52 (95% CI, 162.46-202.26) cases per 100 000 person-years, accounting for 84.44% of the male-female incidence rate difference. Smoking (ARD, 111.87 [95% CI, 95.38-128.00]; AP, 51.75%) and heavy alcohol drinking (ARD, 32.64 [95% CI, 24.61-40.43]; AP, 15.10%) were leading contributors. In the UK population (455 024 participants [53.3% female]), the joint ARD was 52.31 (95% CI, 35.63-70.22) cases per 100 000 person-years, accounting for 26.21% of the sex disparity. Obesity (ARD, 15.34 [95% CI, 6.06-24.08]; AP, 7.68%) and smoking (ARD, 12.49 [95% CI, 1.82-24.39]; AP, 6.26%) were leading individual contributors. Conclusions and Relevance: The findings of this cohort study suggest that modifiable lifestyle factors and health conditions accounted for most of the male-female cancer incidence gap in the Chinese population but only a small fraction in the UK population. Reducing cancer sex disparities may require prevention strategies tailored to population contexts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.